TERF2IP and gastric carcinoma: In a study of pattern expression of MRE11, RAD50, NBS1, and RAP1 in gastric carcinomas, Matsutani et al. (2001) found increased expression of RAP1 in gastric carcinomas compared to their non-neoplastic counterparts in 60% of cases.